Skip to main content
. 2018 May 10;4:57. doi: 10.1038/s41420-018-0060-7

Fig. 4. Effect of NVP-BEZ235 and Cisplatin on cell cycle progression.

Fig. 4

FaDu HSCC cells were treated with NVP-BEZ235, Cisplatin, or a combination of NVP-BEZ235 and Cisplatin for 72 h; the proportion of cells in each phase of the cell cycle was calculated as the percentage of the total cell population. Data presented are the means and SE of three independent experiments